Frequent screening for asymptomatic chlamydia and gonorrhoea infections in men who have sex with men: time to re-evaluate?
- Author(s)
- Williams, E; Williamson, DA; Hocking, JS;
- Details
- Publication Year 2023-07-26,Volume 23,Issue #12,Page e558-e566
- Journal Title
- Lancet Infectious Diseases
- Abstract
- There is increasing debate regarding the harms and benefits of frequent asymptomatic screening for Chlamydia trachomatis and Neisseria gonorrhoeae in men who have sex with men (MSM). One concern is that frequent asymptomatic screening could result in increased antimicrobial resistance in an array of sexually acquired infections and other pathogens, due to selection pressure exerted by frequent broad-spectrum antimicrobial usage within some sexual networks. Here, we outline the harms and benefits of frequent C trachomatis and N gonorrhoeae screening in MSM in high-income settings and propose that screening frequency be reduced. We describe the evidence gaps that should be further explored to better understand the implications of reducing the frequency of asymptomatic C trachomatis and N gonorrhoeae screening in MSM and the surveillance systems that should be in place to prepare for such changes.
- Publisher
- Elsevier
- Keywords
- Male; Humans; *Gonorrhea/diagnosis/epidemiology; Homosexuality, Male; *Chlamydia Infections/diagnosis/epidemiology; Mass Screening; *Sexual and Gender Minorities; Neisseria gonorrhoeae; Chlamydia trachomatis; *Anti-Infective Agents; Prevalence
- Research Division(s)
- Infectious Diseases And Immune Defence
- PubMed ID
- 37516129
- Publisher's Version
- https://doi.org/10.1016/s1473-3099(23)00356-0
- Terms of Use/Rights Notice
- Refer to copyright notice on published article.
Creation Date: 2023-08-04 12:44:10
Last Modified: 2023-11-30 09:12:27